Browse All

Current Filters

CLEAR FILTER x

TITLE

Safety and Tolerability of P2B001 in Patients with Early Parkinson’s Disease: Analysis of an Integrated Phase 2 and 3 Safety Database

Efficacy of ND0612, a 24-hour Subcutaneous Levodopa/Carbidopa Infusion for People with Parkinson’s Disease Experiencing Motor Fluctuations: Subgroup-analyses from a Randomized, Controlled Phase 3 Study